Trial intelligence / Profile preview

rThrombin in Surgical Hemostasis

NCT00491608Phase 3Completed

Sponsor
ZymoGenetics
Start
Jun 2007
Primary completion
Jul 2008
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of thrombin alfa, sponsored by ZymoGenetics. Started Jun 2007; status: completed.

02

Drugs

thrombin alfa

Beyond the preview

Go deeper on NCT00491608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00491608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call